Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1984 of 6351
-
Magic mushroom compound tested for Alzheimer's depression
Symptom relief Recruiting nowThis open-label pilot study examines whether the hallucinogenic drug, psilocybin, given under supportive conditions, is safe and effective for depression in people with Mild Cognitive Impairment (MCI) or early Alzheimer's Disease (AD). This study will also assess whether psilocyb…
Early phase 1 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
New devices could revolutionize cervical cancer screening in africa
Diagnosis Recruiting nowThe study aims to compare the accuracy of the lateral flow test to detect HPV at the POC with commercially available HPV test and to determine the diagnostic accuracy and reliability of a multimodal optical imaging system to detect cervical dysplasia, with the gold reference stan…
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
New pill could help kids with severe psoriasis
Disease control Recruiting nowThe purpose of this pediatric study is to evaluate the drug levels, efficacy and safety of Deucravacitinib in children and adolescent participants aged 4 to \<18 years with moderate to severe plaque psoriasis. This study includes two cohorts; Cohort 1 (age 12 to \<18 years) and C…
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Ketogenic diet may offer pain relief for women with lipedema
Symptom relief CompletedLipedema is a female progressive fat disorder, characterized by a symmetrical increase in subcutaneous adipose tissue in the lower extremities with the exception of the waist. The condition is often misdiagnosed and underdiagnosed. The etiology is poorly understood. Affects about…
Sponsor: Helse Nord-Trøndelag HF • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
Could a simple pill help ICU patients get off IV blood pressure drugs faster?
Disease control Recruiting nowVasopressors are medications that are given intravenously to increase the blood pressure of patients with illnesses that cause dangerous blood pressure drops. When a doctor prescribes a vasopressor, they ask that the dose be adjusted to achieve a specific blood pressure. This kin…
Phase 4 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug combo shows promise for rare blood cancer
Disease control OngoingThe purpose of this study is to assess the safety, tolerability, and efficacy of BMS-986158 alone and in combination with either Ruxolitinib or Fedratinib in participants with Dynamic International Prognostic Scoring System (DIPSS)-intermediate or high risk blood cancer. Part 1 c…
Phase 1/2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New study tests ROSE program to stop postpartum depression before it starts
Prevention Recruiting nowThe purpose of this study is to learn more about pregnant women's' experience with Reach Out, Stay Strong, Essentials for mothers of newborns (ROSE) and to evaluate the effectiveness of the ROSE program in preventing and reducing post-partum depressive symptoms, decreasing stress…
Sponsor: NYU Langone Health • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
New hope for kids with rare sugar disorder: drug shows promise in trial
Disease control CompletedThis study is designed to assess the clinical benefit as well as the safety, pharmacokinetics (PK), and pharmacodynamics (PD) (reduction of galactitol levels) of AT-007 in pediatric subjects with Classic Galactosemia (CG).
Phase 2/3 • Sponsor: Applied Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Brain scans may reveal how MS drug affects mental fatigue
Knowledge-focused CompletedThe purpose of this research study is to investigate the effectiveness of Tysabri on cognitive fatigue in persons with Relapsing-Remitting Multiple Sclerosis (RRMS). Cognitive fatigue is the kind of fatigue that occurs after intense mental concentration as after a session of prob…
Sponsor: Kessler Foundation • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
New contrast mammogram spots hidden breast tumors
Diagnosis CompletedThis clinical trial investigates contrast-enhanced mammography (CEM) in detecting breast cancer. CEM is similar to standard mammography, but it includes an injection of an iodine-based contrast, which makes tissue and blood vessels more visible in scans. Diagnostic procedures, su…
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 26, 2026 17:53 UTC
-
New cocktail of drugs shows promise for tough lung cancer
Disease control OngoingThis phase Ib trial finds the best dose and side effects of ensartinib and its effects when given with carboplatin, pemetrexed and bevacizumab for in treating patients with ALK-positive non-small cell lung cancer that is stage IIIC or IV, or has come back (recurrent). Ensartinib …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a phone app fix chemo brain? new study hopes so
Symptom relief OngoingThe overall purpose of this trial is to confirm the efficacy of Memory and Attention Adaptation Training (MAAT), a cognitive-behavioral therapy (CBT) for treatment of chemotherapy-related cognitive dysfunction among (female or male) breast cancer survivors. This is a multi-center…
Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New tool could predict who will suffer from steroid side effects
Knowledge-focused OngoingTo date, there is no available tool that allows, at individual level, determination of the probability to develop clinically relevant complications of prolonged glucocorticoid therapy. In patients with inflammatory rheumatic disorders requiring prolonged glucocorticoid therapy, s…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Blood test may shield cancer Patients' hearts from chemo damage
Disease control CompletedInvestigators will evaluate the safety and feasibility of a biomarker-guided cardioprotection strategy using NTproBNP, as compared to usual care, in breast cancer and lymphoma patients treated with anthracyclines.
Phase 1/2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo attack: radiation plus surgery for stubborn tumors
Disease control OngoingThe purpose of this study is to learn about the feasibility and safety of using Peptide Receptor Radionuclide Therapy (PRRT) before and after surgical removal of a tumor. PRRT treatment is based on the administration of a radioactive product, 177-Lu DOTA-0-Tyr3-Octreotate (Lutath…
Phase 1 • Sponsor: Stanford University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New drug combo shows promise for tough lung cancers
Disease control CompletedThe objective of this study is to assess safety and efficacy of CAB-AXL-ADC in NSCLC
Phase 2 • Sponsor: BioAtla, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New hope for lung cancer: Drug-Radiation combo trial opens
Disease control Recruiting nowCONCORDE is a multi-institution, multi-arm, Phase IB study that will determine the recommended phase II dose (RP2D) and safety profiles of different DNA damage repair inhibitors (DDRis) when given in an open label fashion in combination with fixed dose curative intent radiotherap…
Phase 1 • Sponsor: University of Leeds • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Personalized vaccine plus immunotherapy shows promise for tough lung cancer
Disease control CompletedThis is a single-arm Phase Ib/II multicenter open-label study, with translational sub-study, of atezolizumab plus autologous dendritic cell vaccine as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC). It is expected that three Spanish sites will include p…
Phase 1/2 • Sponsor: Instituto Oncológico Dr Rosell • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a phone app beat the gold standard for weight loss?
Disease control OngoingThe overall objective of this study is to evaluate the first rigorously optimized, remotely delivered treatment for obesity against the current gold standard treatment in a head-to-head randomized controlled trial. The investigators will be comparing the previously developed and …
Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
Diagnosis OngoingMesenteric traction syndrome (MTS) is defined as hypotension, tachycardia and facial flushing in the first hour of surgery, caused by mesenteric traction/abdominal exploration. MTS occurs frequently during abdominal surgery, with incidence around 80 % during open surgery, and low…
Sponsor: Rigshospitalet, Denmark • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC